Open consultation

Statutory scheme to control costs of branded health service medicines


This consultation seeks views on proposed changes to the statutory scheme to control the costs of branded health medicines.

This consultation is being held on another website.

This consultation closes at

Consultation description

The government is consulting on proposed changes to legislation to ensure that the overall growth of branded medicines sales made to the NHS by pharmaceutical manufacturers in the statutory medicines pricing scheme remains at a sustainable level.

The consultation seeks views on:

  • the methodology for forecasting expected future branded medicines growth
  • proposed changes to the method of calculating a payment percentage, based on allowed growth rates
  • minor technical changes to the products in scope of payment


2018 Statutory Scheme – Branded Medicines Pricing: impact assessment

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 6 August 2018
Last updated 6 August 2018 + show all updates
  1. First published.